Anesthesia and analgesia in oncology: what are the determinants of choice?


Cite item

Full Text

Abstract

About the authors

A. M. Ovechkin

I. M. Sechenov First Moscow State Medical University

References

  1. Горобец Е.С., Гаряев Р.В. Рассуждения о послеоперационном обезболивании и внедрении эпидуральной анальгезии в отечественную хирургическую клинику // Регионарная анестезия и лечение острой боли. 2007. Т. 1, № 1. С. 42-51.
  2. Любошевский П.А., Забусов А.В. Влияние регионарной анестезии на метаболические и воспалительные изменения при абдоминальных операциях // Общая реаниматология. 2011. № 2. С. 31-34.
  3. Марченков Ю.В., Рябчиков М.М., Шульгин М.А. Сравнительная характеристика различных видов послеоперационной анальгезии у больных с онкологическими заболеваниями легких // Общая реаниматология. 2011. № 3. С. 32-37.
  4. Amato A., Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer // Cochrane Database Syst. Rev. 2006; 1: CD005033.
  5. Bar-Yosef S., Melamed R., Page G. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats // Anesthesiology. 2001; 94: 1066-1073.
  6. Beilin B., Shavit Y., Hart J. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period // Anesth. Analg. 1996; 82: 492-497.
  7. Beilin B., Shavit Y., Razumovsky J. Effect of mild perioperative hypothermia on cellular immune responses // Anesthesiology. 1998; 89: 1133-1140.
  8. Ben-Eliahu S., Shakhar G., Rosenne E. Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mechanisms // Anesthesiology. 1999; 91: 732-740.
  9. Ben-Eliahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology // Brain Behav. Immun. 2003; 17 (Suppl.): 27-36.
  10. Benish M., Bartal I., Golgfarb Y. Perioperative use of betablockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis // Ann. Surg. Oncol. 2008; 15: 2042-2052.
  11. Biki B., Mascha E., Moriarty D. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis // Anesthesiology. 2008; 109: 180-187.
  12. Brand J., Kirchner H., Poppe C. The effect of general anesthesia on human peripheral immune cell distribution and cytokine production // Clin. Immunol. Immunopathol. 1997; 83: 190-194.
  13. Bruzzone A., Pinero C., Castillo L. Alpha2 - adrenoreceptor action on cell proliferation and mammary tumor growth in mice // Br. J. Pharmacol. 2008; 155: 494-504.
  14. Chae B., Lee H., Sun K. The effect of combined epidural and light general anesthesia on stress hormones in open heart surgery patients // Surg. Today. 1998; 28: 727-731.
  15. Chen G., Zhang F., Gong M. Effect of perioperative autologuos versus allogenic blood transfusion on the immune system in gastric cancer patients // J. Zhejiang Univ. Sci. 2007; 8: 560-565.
  16. Christopherson R., James K., Tableman M. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia // Anesth. Analg. 2008; 107: 325-332.
  17. Coffey J., Wang J., Smith M. Excisional surgery for cancer cure: therapy at a cost // Lancet Oncol. 2004; 4: 760-768.
  18. Deegan S., Murray D., Doran P. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro // Br. J. Anaesth. 2009; 103: 685-690.
  19. Denis M., Lipart C., Leborgne J. Detection of disseminated tumor cells in peripheral bllod of colorectal cancer patients // Int. J. Cancer. 1997; 74: 540-544.
  20. Exadactylos A., Buggy D., Moriarty D. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? // Anesthesiology. 2006; 105: 660-664.
  21. Farooqui M., Rogers T., Poonawala T. COX-2 inhibitor cele-coxib prevents chronic morphine-induced promotion of angio-genesis, tumor growth, metastasis and mortality, without compromising analgesia // Br. J. Cancer. 2007; 97: 1523-1531.
  22. Galley H., Dubbels A., Webster N. The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leucocytes // Anesth. Analg. 1998; 86: 1289-1293.
  23. Gaspani L., Bianchi M., Limiroli E. The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats // J. Neuroimmunol. 2002; 129: 18-24.
  24. Goldfarb Y., Ben-Eliahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches // Breast. Dis. 2006; 26: 99-114.
  25. Gottschalk A., Sharma S., Ford J. The role of the perioperative period in recurrence after cancer surgery // Anesth. Analg. 2010; 110: 1636-1643.
  26. Gottschalk A., Ford J., Regelin C. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery // Anesthesiology. 2010; 113: 27-34.
  27. Gupta G., Massague J. Cancer metastasis: building a framework // Cell. 2006; 127: 679-695.
  28. Gupta A., Bjornsson A., Fredriksson M. Reduction of mortality after epidural anaesthesia and analgesia in patients undergoing rectal but non colonic cancer surgery: a retrospective analysis of data from 655 patients in Central Sweden // Br. J. Anaesth. 2011; 107: 164-170.
  29. Harris R., Beebe-Donk J., Alshafie G. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors // BMC Cancer. 2006; 6: 27.
  30. Hasegawa H., Saiki I. Psychosocial stress augments tumor development through beta-adrenergic activation in mice // Jpn. J. Cancer Res. 2002; 93: 729-735.
  31. Inada T., Ymanaoichi Y., Jomura S. Effect of propofol and isoflurane anaesthesia on the immune response to surgery // Anaesthesia. 2004; 59: 954-959.
  32. Inada T., Kubo K., Kambara T. Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells // Can. J. Anaesth. 2009; 56: 222-229.
  33. Jones M., Wang H., Pescar B. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing // Nat. Med. 1999; 5: 1418-1423.
  34. Ke J., Zhan J., Feng X. A comparison of the effect of total intravenous anesthesia with propofol and remifentanil and inhalation anesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy // Anaesth. Int. Care. 2008; 36: 74-78.
  35. Kundu J., Surh Y. Inflammation: gearing the journey to cancer // Mutat Res. 2008; 659: 15-30.
  36. Kushida A., Inada T., Shingu K. Enhancement of antitumor immunity after propofol treatment in mice // Immunopharmacol. Immunotoxicol. 2007; 29: 477-486.
  37. Leahy K., Ornberg R., Wang Y. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo // Cancer Res. 2002; 62: 625-631.
  38. Lennon F., Moss J., Singleton P.The μ-opioid receptor in cancer progression. Is there a direct effect? // Anesthesiology. 2012; 116: 940-945.
  39. Lutgendorf S., Cole S., Costanzo E. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines // Clin. Cancer. Res. 2003; 9: 45144521.
  40. Mammoto T., Mukai M., Mammoto A. Intravenous anesthetic propofol inhibits invasion of cancer cells // Cancer Lett. 2002; 184: 165-170.
  41. Mammoto T., Higashiyama S., Mukai M. Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulation ectodomain shedding of heparin-binding epidermal growth factor-like growth factor (HB-EGF) // J. Cell. Physiol. 2002; 192: 351-358.
  42. Markovic S., Knidht P., Murasko D. Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane // Anesthesiology. 1993; 78: 700-706.
  43. Martinsson T. Ropivacaine inhibits serum-induced proliferation of colon adenocarcinoma cells in vitro // J. Pharmacol. Exp. Ther. 1999; 288: 660-664.
  44. Melamed R., Bar-Yosef S., Shakhar G. Supression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental and halothane, but not by propofol: mediating mechanisms and prophylactic measures // Anesth. Analg. 2003; 97: 1331-1339.
  45. Melamed R., Rosenne E., Shakhar K. Marginating pulmonary NK-activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor // Brain Behav. Immun. 2005; 19: 114-126.
  46. Mitsuhata H., Shimizu R., Yokoyama M. Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells // Int. J. Jmmunopharmacol. 1995; 17: 529-534.
  47. Page G., Blakely W., Ben-Eliahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats // Pain. 2001; 90: 191-199.
  48. Procopio M., Rassias A., DeLeo J. The in vivo effects of general and epidural anesthesia on human immune function // Anesth. Analg. 2001; 93: 460-465.
  49. Roche-Nagle G., Connolly E., Eng M. Antimetastatic activity of a cyclooxygenase-2 inhibitor // Br. J. Cancer. 2004; 91: 359-365.
  50. Sacerdote P., Bianchi M., Gaspani L. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients // Anesth. Analg. 2000; 90: 1411-1414.
  51. Sakaguchi M., Kuroda Y., Hirose M. The antiproliferative effect of lidocaine of human tongue cancer with inhibition of the activity of epidermal growth factor receptor // Anesth. Analg. 2006; 102: 1103-1107.
  52. Schlagenhauff B., Ellwanger U., Breuninger H. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma // Melanoma Res. 2000; 10: 165-169.
  53. Sessler D. Does regional analgesia reduce the risk of cancer recurrence? A hypothesis // Eur. J. Cancer Prev. 2007; 17: 269-272.
  54. Shavit Y., Ben-Eliahu S., Zeidel A. Effects of fentanil on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study // Neuroimmunomodulation. 2004; 11: 255-260.
  55. Smith T., Staats P., Deer T. Implantable drug delivery systems study group: randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity and survival // J. Clin. Oncol. 2002; 20: 4040-4049.
  56. Snyder G., Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence // Br. J. Anaesth. 2010; 105: 106-115.
  57. Sood A., Bhatty R., Kamat A. Stress hormone-mediated invasion of ovarian cancer cells // Clin. Cancer Res. 2006; 12: 369-375.
  58. Thaker P., Han L., Kamat A. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma // Nat. Med. 2006; 12: 939-944.
  59. Thaker P., Sood A. Neuroendocrine influences on cancer biology // Semin. Cancer Biol. 2008; 18: 164-170.
  60. Tsuchiya M., Asada A., Arita K. Induction and mechanism of apoptotic cell death by propofol in HL-60 cells // Acta An-aesth. Scand. 2002; 46: 1068-1074.
  61. Tsui B., Rashiq S., Schopflocher D. Epidural anesthesia and cancer recurrence after radical prostatectomy // Can. J. Anaesth. 2010; 57: 107-112.
  62. Wada H., Seki S., Takahashi T. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance // Anesthesiology. 2007; 106: 499-506.
  63. Weber R., Jabbour N., Martin R. Anemia and transfusions in patients undergoing surgery for cancer // Ann. Surg. Oncol. 2008; 15: 34-45.
  64. Weimann J. Toxicity of nitrous oxide // Best Pract. Res. 2003; 17: 47-61.
  65. Wojtowicz-Praga S. Reversal of tumor-induced immunosupression by TGF-beta inhibitors // Invest. New Drugs. 2003; 21: 21-32.
  66. Yeager M., DeLeo J., Arruda J. Intravenous fentanil increases natural killer cel cytotoxicity and circulating CD16+ lymphocytes in humans // Anesth. Analg. 2002; 94: 94-99.

Copyright (c) 2012 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies